They should be well in the running with their proven record in such developments, but will there be the margins in contracts to boost earnings sufficiently to get the sp moving.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
PDI Chris Judd’s Talk Ya Book: Predictive Discovery finally coming to its 'pointy end' - and it's gunning for gold